Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Taiwan permanently bans weight loss drug Belviq
2 Weight-loss drug banned
3 Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says
4 What Lorcaserin Did for Me
5 Weight-loss drug Belviq recalled
6 Weight Loss Drug Belviq Found to Increase Cancer Risk, Pulled from Shelves
7 CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA
8 As one drug leaves the weight-loss market, many options remain
9 Diet Drug Belviq May Raise Cancer Risk: FDA
10 Hudson Valley woman claims Belviq weight-loss drugmaker knew of cancer risk
11 Weight Loss Drug Belviq Pulled From Market for Possible Cancer Risk
12 Diet drug Belviq pulled from shelves for possible link to cancer risk
13 FDA Warns Consumers to Stop Using Belviq® (Lorcaserin) Weight Loss Drug Due to Increased Cancer Risk • LegalScoops
14 Alvogen's obesity drug threatens Novo Nordisk's stronghold in Korea
15 FDA drug recall: Weight loss pill may increase cancer risk
16 FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk
17 FDA requests market withdrawal of weight-loss drug Belviq
18 Covid-19 Impact on 2020 Global Anti-Obesity Prescription Drugs Market: Showing Footprints for Strong Annual Sales By 2027
19 Weight-loss drug Belviq increases risk of cancer, FDA warns
20 Did Patients Trade Weight Loss Concerns for Cancer Concerns?
21 Class-Action Lawsuit Filed Against Makers of Dangerous Weight Loss Drug Belviq
22 Obesity in adults: a clinical practice guideline
23 FDA Recalls Weight Loss Pill Belviq Due To Increased Cancer Risk
24 Despite Obesity Epidemic, Doctors Don't Prescribe Obesity Drugs
25 Zydus Cadila gets tentative USFDA nod for Lorcaserin Hydrochloride Tablets to treat obesity
26 Eisai may be the biggest loser, but it's not the only loser with Belviq withdrawal
27 Drugs Helped Stop Weight Regain After Gastric Bypass
28 Liraglutide a Viable Add-On for Kids With Obesity
29 NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
30 Zydus receives tentative USFDA approval for Lorcaserin Hydrochloride Tabs
31 FDA: Weight Loss Drug May Increase Cancer Risk
32 Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
33 FDA Accepts Eisai's Supplemental New Drug Application (sNDA) to Update the Labeling for Anti-Obesity Agent BELVIQ® (lorcaserin HCl)
34 VVUS: Fourth Quarter and Full Year 2019 Results
35 FDA: Weight loss drug Belviq linked to several types of cancer, pulled from U.S. market
36 Newly discovered brain response to obesity drug may inform future treatments
37 NICE rejections continue, hitting Novo's Saxenda next
38 The diet pills that may help you lose weight and are backed by scientific research
39 Battle for weight loss continues | News, Sports, Jobs
40 Regulator pushed voluntary recall of Belviq without data review
41 Novo Nordisk taps Noom for digital help with its push into obesity
42 The Latest Weight Loss Pills That Work—And the Ones That Don't
43 New Safer Diet Drugs
44 To Your Good Health: The battle for weight loss continues
45 FDA Recalls Weight-Loss Drug Due to Heightened Cancer Risk
46 Doctors warn against use of weight-loss drug
47 More Anti-Obesity Drugs for Teens Coming, Devices Are Next Step
48 Experts rated weight-loss drugs and Qsymia came out on top
49 Friday Frontline: Cancer Updates, Research and Education on January 17, 2020
50 Novo Nordisk's big obesity ambitions take shape with semaglutide win
51 FDA accepts request for CV safety data inclusion for obesity drug
52 Drugmaker cancels event for 1000 doctors due to new coronavirus risk
53 Look back at pharma news in the week to February 14, 2020
54 #VisualAbstract: A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
55 Weight Loss Pills and Supplements: Do They Work?
56 Will Novo’s big thinking in obesity pay off?
57 Can a new generation of weight-loss drugs finally help patients win at the losing game?
58 Eisai obesity drug Belviq may have an edge with new heart-safety data—but to what end?
59 Metformin May Stop Weight Regain After Initial Loss
60 Which Weight-Loss Drug Works Best?
61 Coadministration of phentermine, lorcaserin increases weight loss, not adverse events in adults with obesity
62 Weight Loss and Obesity Management Market to Surpass US$ 294.2 Billion, Globally, by 2027 at a CAGR of 7.1%, Says Coherent Market Insights
63 U.S. weight loss drug lorcaserin 'safe' but only modestly effective
64 Five diet drugs: which ones work?
65 Lorcaserin Is Safe, 'Moves Needle' for Weight Loss in CAMELLIA
66 More CAMELLIA: Obesity Drug Lorcaserin May Avert Diabetes
67 FDA Approves Liraglutide (Saxenda) for Weight Loss
68 Is Contrave Worth Trying?
69 Obesity Drug Belviq Is Heart Safe in Cardiovascular Outcome Study
70 Slippery Slope: Diet Drugs No Help for Heart
71 Pharmacotherapy effective weight-loss option in PCOS with obesity
72 Everything you need to know about lorcaserin
73 Pernix-Backed Biz Picks Up Orexigen's Weight Loss Drug for $74M
74 Obesity Market Spotlight, 2020: Epidemiology, Marketed & Pipeline Drugs, Revenue Opportunities, Clinical Trial Landscape
75 Weight-loss pill hailed as 'holy grail' in fight against obesity
76 EPX-200
77 Contrave, Newest Weight Loss Option: FAQ
78 Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
79 50 Pounds Lighter, Reporter Still Belviq Fan
80 Eisai takes control of weight loss drug Belviq from Arena
81 Belviq: 5 Things You Need to Know About the New Weight-Loss Pill |
82 Diet Pills: Approved, Yes. Prescribed? Maybe
83 Liraglutide as Saxenda for Obesity
84 Lorcaserin and Phentermine Safe Combo in Weight-Loss Trial
85 Saxenda debuts in US with $1000-a-month price tag
86 Weight Loss and Adverse Events With Pharmacological Therapy for Obesity
87 Naltrexone/Bupropion Approved as Mysimba for Obesity in EU
88 Weight-loss pill Belviq is NOT Recommend
89 Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
90 Are Diet Pills or Surgery Cures for Obesity?
91 Higher-Dose Liraglutide Creates New Options to Fight Obesity, but Payment Remains a Challenge
92 A new anti-obesity drug has been approved, but that doesn't mean insurers will pay for it
93 New weight-loss drug available
94 A capsule tricks your stomach into feeling full; could it treat obesity?
95 Takeda's obesity drug Contrave launches in US
96 Weight Loss And Obesity Management Market Growth With Healthy CAGR of 7.1% to reach US$ 294.2 Billion till 2027 | Global Size, Trends Insight, Share, Industry Demand, Comprehensive Analysis and Forecast to 2020 |
97 Pernix Therapeutics Buys Bankrupt Orexigen's Weight Loss Drug for $73.5 Million
98 5 Weight Loss Drugs Approved by FDA
99 BELVIQ® (lorcaserin HCl) CIV Data Featured in Five Abstracts to be Presented at ObesityWeek(SM) 2013
100 Lorcaserin May Help Delay or Manage Type 2 Diabetes, Study Finds